SP
BravenNow
Prelude Therapeutics director David P. Bonita acquires $12.5 million in stock
| USA | economy | ✓ Verified - investing.com

Prelude Therapeutics director David P. Bonita acquires $12.5 million in stock

Entity Intersection Graph

No entity connections available yet for this article.

}

Source

investing.com

More from USA

News from Other Countries

🇬🇧 United Kingdom

🇺🇦 Ukraine